Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases

Details for Australian Patent Application No. 2008220967 (hide)

Owner Medizinische Hochschule Hannover Helmholtz-Zentrum fur Infektionsforschung GmbH

Inventors Malek, Nisar; Hinkelmann, Bettina; Sasse, Florenz; Frank, Ronald; Nickeleit, Irina; Steinmetz, Heinrich

Agent Pizzeys

Pub. Number AU-A-2008220967

PCT Pub. Number WO2008/104387

Priority 60/965,932 22.08.07 US; 07004185.0 28.02.07 EP

Filing date 27 February 2008

Wipo publication date 4 September 2008

International Classifications

A61K 31/4045 (2006.01)

A61K 31/405 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

C07D 519/04 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/104387 Priority application(s): WO2008/104387

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008220972-Can having an easy opening panel, an easy opening panel, and panel therefore

2008220946-Metered-dose inhaler